Inj, glycopyrrolate, 0.1 mg
Products billed under this code include Glycopyrrolate Injection.
Payment limit per 0.1 MG, by effective quarter, 1Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Glycopyrrolate Injection.
Payment limit per 0.1 MG, by effective quarter, 1Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Glycopyrrolate Injection | Hikma Pharmaceuticals USA Inc. | 00143-9584-10 | 400 | $132.00 |
| Glycopyrrolate Injection | Hikma Pharmaceuticals USA Inc. | 00143-9585-25 | 250 | $82.50 |
| Glycopyrrolate Injection | Hikma Pharmaceuticals USA Inc. | 00143-9586-25 | 100 | $33.00 |
| Glycopyrrolate Injection | Hikma Pharmaceuticals USA Inc. | 00143-9587-25 | 50 | $16.50 |
| Glycopyrrolate Injection | Hikma Pharmaceuticals USA Inc. | 00143-9679-10 | 400 | $132.00 |
| Glycopyrrolate Injection | Hikma Pharmaceuticals USA Inc. | 00143-9680-25 | 250 | $82.50 |
| Glycopyrrolate Injection | Hikma Pharmaceuticals USA Inc. | 00143-9681-25 | 100 | $33.00 |
| Glycopyrrolate Injection | Hikma Pharmaceuticals USA Inc. | 00143-9682-25 | 50 | $16.50 |
| Glycopyrrolate Injection | Henry Schein Inc. | 00404-9775-01 | 2 | $0.66 |
| Glycopyrrolate Injection | Henry Schein Inc. | 00404-9776-05 | 10 | $3.30 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Glycopyrrolate Injection | Henry Schein Inc. | 00404-9777-20 | 40 | $13.20 |
| Glycopyrrolate Injection | Henry Schein Inc. | 00404-9782-02 | 4 | $1.32 |
| Glycopyrrolate Injection | Henry Schein Inc. | 00404-9867-01 | 2 | $0.66 |
| Glycopyrrolate Injection | Henry Schein Inc. | 00404-9868-20 | 40 | $13.20 |
| Glycopyrrolate Injection | Henry Schein Inc. | 00404-9869-02 | 4 | $1.32 |
| Glycopyrrolate Injection | Henry Schein Inc. | 00404-9870-05 | 10 | $3.30 |
| Glycopyrrolate Injection | American Regent, Inc. | 00517-4601-25 | 50 | $16.50 |
| Glycopyrrolate Injection | American Regent, Inc. | 00517-4602-25 | 100 | $33.00 |
| Glycopyrrolate Injection | American Regent, Inc. | 00517-4605-25 | 250 | $82.50 |
| Glycopyrrolate Injection | American Regent, Inc. | 00517-4620-25 | 1000 | $330.00 |
| Glycopyrrolate Injection | Hikma Pharmaceuticals USA Inc. | 00641-6212-10 | 20 | $6.60 |
| Glycopyrrolate Injection | Hikma Pharmaceuticals USA Inc. | 00641-6213-10 | 40 | $13.20 |
| Glycopyrrolate Injection | Sandoz Inc. | 00781-3825-96 | 50 | $16.50 |
| Glycopyrrolate Injection | Sandoz Inc. | 00781-3827-96 | 100 | $33.00 |
| Glycopyrrolate Injection | Sandoz Inc. | 00781-3829-96 | 250 | $82.50 |
| Glycopyrrolate Injection | Sandoz Inc. | 00781-3831-95 | 400 | $132.00 |
| Glycopyrrolate Injection | Sagent Pharmaceuticals | 25021-0796-01 | 50 | $16.50 |
| Glycopyrrolate Injection | Sagent Pharmaceuticals | 25021-0796-02 | 100 | $33.00 |
| Glycopyrrolate Injection | Sagent Pharmaceuticals | 25021-0796-05 | 250 | $82.50 |
| Glycopyrrolate Injection | A-S Medication Solutions | 50090-4513-00 | 2 | $0.66 |
| Glycopyrrolate Injection | A-S Medication Solutions | 50090-5226-00 | 50 | $16.50 |
| Glycopyrrolate Injection | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1487-01 | 2 | $0.66 |
| Glycopyrrolate Injection | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1487-03 | 50 | $16.50 |
| Glycopyrrolate Injection | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1554-03 | 100 | $33.00 |
| Glycopyrrolate Injection | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1601-01 | 10 | $3.30 |
| Glycopyrrolate Injection | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1601-03 | 250 | $82.50 |
| Glycopyrrolate Injection | Apotex Corp | 60505-6179-05 | 50 | $16.50 |
| Glycopyrrolate Injection | Apotex Corp | 60505-6180-05 | 100 | $33.00 |
| Glycopyrrolate Injection | Apotex Corp | 60505-6181-05 | 250 | $82.50 |
| Glycopyrrolate Injection | Apotex Corp | 60505-6182-04 | 400 | $132.00 |
| Glycopyrrolate Injection | Alembic Pharmaceuticals Inc. | 62332-0607-25 | 50 | $16.50 |
| Glycopyrrolate Injection | Alembic Pharmaceuticals Inc. | 62332-0627-25 | 100 | $33.00 |
| Glycopyrrolate Injection | Alembic Pharmaceuticals Inc. | 62332-0628-25 | 250 | $82.50 |
| Glycopyrrolate Injection | Alembic Pharmaceuticals Inc. | 62332-0629-10 | 400 | $132.00 |
| Glycopyrrolate Injection | FreseniUS Kabi USA, LLC | 63323-0578-01 | 50 | $16.50 |
| Glycopyrrolate Injection | FreseniUS Kabi USA, LLC | 63323-0578-02 | 100 | $33.00 |
| Glycopyrrolate Injection | FreseniUS Kabi USA, LLC | 63323-0578-05 | 250 | $82.50 |
| Glycopyrrolate Injection | FreseniUS Kabi USA, LLC | 63323-0578-11 | 50 | $16.50 |
| Glycopyrrolate Injection | FreseniUS Kabi USA, LLC | 63323-0578-12 | 100 | $33.00 |
| Glycopyrrolate Injection | FreseniUS Kabi USA, LLC | 65219-0801-01 | 50 | $16.50 |
| Glycopyrrolate Injection | Piramal Critical Care Inc | 66794-0202-42 | 50 | $16.50 |
| Glycopyrrolate Injection | Piramal Critical Care Inc | 66794-0203-42 | 100 | $33.00 |
| Glycopyrrolate Injection | Piramal Critical Care Inc | 66794-0204-42 | 250 | $82.50 |
| Glycopyrrolate Injection | Piramal Critical Care Inc | 66794-0205-41 | 400 | $132.00 |
| Glycopyrrolate Injection | Somerset Pharma, LLC | 70069-0616-10 | 400 | $132.00 |
| Glycopyrrolate Injection | Somerset Pharma, LLC | 70069-0617-25 | 50 | $16.50 |
| Glycopyrrolate Injection | Somerset Pharma, LLC | 70069-0618-25 | 100 | $33.00 |
| Glycopyrrolate Injection | Somerset Pharma, LLC | 70069-0619-25 | 250 | $82.50 |
| Glycopyrrolate Injection | Amneal Pharmaceuticals, LLC | 70121-1698-07 | 20 | $6.60 |
| Glycopyrrolate Injection | Amneal Pharmaceuticals, LLC | 70121-1699-07 | 40 | $13.20 |
| Glycopyrrolate Injection | Xiromed, LLC | 70700-0165-25 | 50 | $16.50 |
| Glycopyrrolate Injection | Xiromed, LLC | 70700-0166-25 | 100 | $33.00 |
| Glycopyrrolate Injection | Xiromed, LLC | 70700-0167-25 | 250 | $82.50 |
| Glycopyrrolate Injection | Xiromed, LLC | 70700-0168-23 | 400 | $132.00 |
| Glycopyrrolate Injection | Xiromed, LLC | 70700-0902-25 | 250 | $82.50 |
| Glycopyrrolate Injection | Xiromed, LLC | 70700-0903-23 | 400 | $132.00 |
| Glycopyrrolate Injection | Athenex Pharmaceutical Division, LLC | 70860-0781-01 | 50 | $16.50 |
| Glycopyrrolate Injection | Athenex Pharmaceutical Division, LLC | 70860-0781-02 | 100 | $33.00 |
| Glycopyrrolate Injection | Athenex Pharmaceutical Division, LLC | 70860-0781-05 | 250 | $82.50 |
| Glycopyrrolate Injection | Athenex Pharmaceutical Division, LLC | 70860-0781-20 | 400 | $132.00 |
| Glycopyrrolate Injection | Meitheal Pharmaceuticals Inc. | 71288-0414-03 | 50 | $16.50 |
| Glycopyrrolate Injection | Meitheal Pharmaceuticals Inc. | 71288-0414-04 | 100 | $33.00 |
| Glycopyrrolate Injection | Meitheal Pharmaceuticals Inc. | 71288-0414-92 | 50 | $16.50 |
| Glycopyrrolate Injection | Meitheal Pharmaceuticals Inc. | 71288-0414-94 | 100 | $33.00 |
| Glycopyrrolate Injection | Meitheal Pharmaceuticals Inc. | 71288-0415-06 | 250 | $82.50 |
| Glycopyrrolate Injection | Meitheal Pharmaceuticals Inc. | 71288-0415-21 | 400 | $132.00 |
| Glycopyrrolate Injection | Meitheal Pharmaceuticals Inc. | 71288-0415-96 | 250 | $82.50 |
| Glycopyrrolate Injection | BE Pharmaceuticals Inc. | 71839-0123-25 | 50 | $16.50 |
| Glycopyrrolate Injection | BE Pharmaceuticals Inc. | 71839-0124-25 | 100 | $33.00 |
| Glycopyrrolate Injection | BE Pharmaceuticals Inc. | 71839-0125-25 | 250 | $82.50 |
| Glycopyrrolate Injection | Civica, Inc. | 72572-0225-25 | 25 | $8.25 |
| Glycopyrrolate Injection | Civica, Inc. | 72572-0226-25 | 50 | $16.50 |
| Glycopyrrolate Injection | FreseniUS Kabi USA, LLC | 76045-0203-10 | 48 | $15.84 |
| Glycopyrrolate Injection | FreseniUS Kabi USA, LLC | 76045-0203-20 | 96 | $31.68 |
| Glycopyrrolate Injection | FreseniUS Kabi USA, LLC | 76045-0206-10 | 48 | $15.84 |
| Glycopyrrolate Injection | FreseniUS Kabi USA, LLC | 76045-0208-20 | 96 | $31.68 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.33 | −$0.035 | 0.1 MG | Inj, glycopyrrolate, 0.1 mg | v1, posted September 17, 2026 |
| 3Q26 | $0.365 | $0.00 | 0.1 MG | Inj, glycopyrrolate, 0.1 mg | v1, posted September 15, 2026 |
| 2Q26 | $0.365 | −$0.01 | 0.1 MG | Inj, glycopyrrolate, 0.1 mg | v1, posted September 15, 2026 |
| 1Q26 | $0.375 | −$0.082 | 0.1 MG | Inj, glycopyrrolate, 0.1 mg | v1, posted September 15, 2026 |
| 4Q25 | $0.457 | +$0.024 | 0.1 MG | Inj, glycopyrrolate, 0.1 mg | v1, posted September 8, 2026 |
| 3Q25 | $0.433 | −$0.076 | 0.1 MG | Inj, glycopyrrolate, 0.1 mg | v1, posted March 10, 2026 |
| 2Q25 | $0.509 | −$0.067 | 0.1 MG | Inj, glycopyrrolate, 0.1 mg | v1, posted March 10, 2026 |
| 1Q25 | $0.576 | +$0.066 | 0.1 MG | Inj, glycopyrrolate, 0.1 mg | v1, posted December 19, 2025 |
| 4Q24 | $0.51 | +$0.055 | 0.1 MG | Inj, glycopyrrolate, 0.1 mg | v1, posted June 11, 2025 |
| 3Q24 | $0.455 | −$0.042 | 0.1 MG | Inj, glycopyrrolate, 0.1 mg | v1, posted June 11, 2025 |
| 2Q24 | $0.497 | −$0.119 | 0.1 MG | Inj, glycopyrrolate, 0.1 mg | v1, posted March 11, 2025 |
| 1Q24 | $0.616 | – | 0.1 MG | Inj, glycopyrrolate, 0.1 mg | v1, posted December 19, 2024 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.